Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2023-05-24 Purchase | 2023-05-25 4:07 pm | Prelude Therapeutics Inc | PRLD | Lim Bryant David Chief Legal Officer, Corp Sec. | 2,400 | $5.39 | $12,936 | 2,400 (Direct) | View |
2021-03-25 Sale | 2021-03-29 4:09 pm | IDERA PHARMACEUTICALS INC. | IDRA | Lim Bryant David SVP AND GENERAL COUNSEL | 7,630 | $1.3601 | $10,378 | 30,434 (Direct) | View |
2021-01-12 Sale | 2021-01-12 7:08 pm | IDERA PHARMACEUTICALS INC. | IDRA | Lim Bryant David SVP and General Counsel | 1,711 | $4.2091 | $7,202 | 89,064 (Direct) | View |
2021-01-05 Sale | 2021-01-11 8:15 pm | IDERA PHARMACEUTICALS INC. | IDRA | Lim Bryant David SVP and General Counsel | 1,465 | $3.9058 | $5,722 | 39,775 (Direct) | View |
2020-01-08 Sale(A) | 2020-01-14 6:10 pm | IDERA PHARMACEUTICALS INC. | IDRA | Lim Bryant David SVP and General Counsel | 1,603 | $1.7804 | $2,854 | 21,240 (Direct) | View |
2020-01-07 Sale | 2020-01-10 08:07 am | IDERA PHARMACEUTICALS INC. | IDRA | Lim Bryant David SVP and General Counsel | 1,603 | $1.7804 | $2,854 | 21,240 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-05-14 Option Award | 2024-05-16 4:00 pm | N/A 2034-05-13 | Prelude Therapeutics Inc | PRLD | Lim Bryant David CLO, Interim CFO, Corp Sec. | 25,000 | $0 | 25,000 (Direct) | View |
2024-03-01 Option Award | 2024-03-04 6:07 pm | N/A 2034-02-28 | Prelude Therapeutics Inc | PRLD | Lim Bryant David Chief Legal Officer, Corp Sec. | 150,000 | $0 | 150,000 (Direct) | View |
2023-03-01 Option Award | 2023-03-02 4:06 pm | N/A 2033-02-28 | Prelude Therapeutics Inc | PRLD | Lim Bryant David Chief Legal Officer, Corp Sec. | 250,000 | $0 | 250,000 (Direct) | View |
2023-01-20 Option Award | 2023-02-02 8:08 pm | N/A 2033-01-20 | Aceragen Inc. | ACGN | Lim Bryant David SVP AND GENERAL COUNSEL | 25,400 | $0 | 25,400 (Direct) | View |
2023-01-06 Option Award | 2023-01-10 9:17 pm | N/A N/A | IDERA PHARMACEUTICALS INC. | IDRA | Lim Bryant David SVP AND GENERAL COUNSEL | 399,218 | $0 | 309,695 (Direct) | View |
2023-01-06 Tax Withholding | 2023-01-10 9:17 pm | N/A N/A | IDERA PHARMACEUTICALS INC. | IDRA | Lim Bryant David SVP AND GENERAL COUNSEL | 119,957 | $0.7099 | 309,695 (Direct) | View |
2022-07-06 Option Award | 2022-07-07 5:33 pm | N/A 2032-07-06 | IDERA PHARMACEUTICALS INC. | IDRA | Lim Bryant David SVP AND GENERAL COUNSEL | 66,500 | $0 | 66,500 (Direct) | View |
2022-04-01 Option Award | 2022-04-04 5:44 pm | N/A 2032-04-01 | IDERA PHARMACEUTICALS INC. | IDRA | Lim Bryant David SVP AND GENERAL COUNSEL | 41,500 | $0 | 41,500 (Direct) | View |
2022-01-24 Option Award | 2022-01-26 8:43 pm | N/A 2032-01-24 | IDERA PHARMACEUTICALS INC. | IDRA | Lim Bryant David SVP AND GENERAL COUNSEL | 25,000 | $0 | 25,000 (Direct) | View |
2021-07-08 Option Award | 2021-07-12 4:05 pm | N/A 2031-07-08 | IDERA PHARMACEUTICALS INC. | IDRA | Lim Bryant David SVP AND GENERAL COUNSEL | 66,500 | $0 | 66,500 (Direct) | View |
2021-01-08 Option Award | 2021-01-12 7:08 pm | N/A 2031-01-08 | IDERA PHARMACEUTICALS INC. | IDRA | Lim Bryant David SVP and General Counsel | 51,000 | $0 | 89,064 (Direct) | View |
2020-07-21 Option Award | 2020-07-23 4:37 pm | N/A 2030-07-21 | IDERA PHARMACEUTICALS INC. | IDRA | Lim Bryant David SVP and General Counsel | 50,000 | $0 | 50,000 (Direct) | View |
2020-01-10 Option Award | 2020-01-14 6:56 pm | N/A 2030-01-10 | IDERA PHARMACEUTICALS INC. | IDRA | Lim Bryant David SVP and General Counsel | 70,000 | $0 | 91,240 (Direct) | View |